State of Alaska Department of Revenue’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$881K Sell
28,580
-13,285
-32% -$328K 0.01% 1134
2026
Q1
$904K Sell
41,865
-1,586
-4% -$34.3K 0.01% 1128
2025
Q4
$1.03M Buy
43,451
+8,642
+25% +$176K 0.01% 1054
2025
Q3
$473K Sell
34,809
-5,513
-14% -$57.3K ﹤0.01% 1422
2025
Q2
$327K Buy
40,322
+3,034
+8% +$25.9K ﹤0.01% 1494
2025
Q1
$292K Buy
37,288
+6,688
+22% +$77.5K ﹤0.01% 1507
2024
Q4
$455K Sell
30,600
-183
-0.6% -$2.99K 0.01% 1423
2024
Q3
$470K Sell
30,783
-1,258
-4% -$19.8K 0.01% 1430
2024
Q2
$487K Sell
32,041
-890
-3% -$14.4K 0.01% 1368
2024
Q1
$621K Sell
32,931
-227
-0.7% -$3.92K 0.01% 1274
2023
Q4
$633K Sell
33,158
-241
-0.7% -$3.85K 0.01% 1237
2023
Q3
$599K Sell
33,399
-1,235
-4% -$24.8K 0.01% 1237
2023
Q2
$703K Sell
34,634
-1,066
-3% -$20.3K 0.01% 1178
2023
Q1
$651K Sell
35,700
-602
-2% -$11.5K 0.01% 1228
2022
Q4
$750K Buy
36,302
+332
+0.9% +$9.14K 0.01% 1133
2022
Q3
$940K Buy
35,970
+710
+2% +$18.8K 0.01% 955
2022
Q2
$893K Buy
+35,260
New +$863K 0.01% 1034

Other funds holding RCUS

State of Alaska Department of Revenue's RCUS Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Arcus Biosciences (RCUS) stake by 32% in Q2 2026, selling an estimated $328K and leaving 28,580 shares worth $881K. The position accounts for 0.01% of the portfolio, ranked #1134.

State of Alaska Department of Revenue first reported a position in RCUS in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.03M in Q4 2025. 117 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • State of Alaska Department of Revenue held 28,580 shares of Arcus Biosciences worth $881K as of Q2 2026.
  • State of Alaska Department of Revenue sold 13,285 Arcus Biosciences shares in Q2 2026, an estimated $328K.
  • Arcus Biosciences made up 0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1134 holding.
  • State of Alaska Department of Revenue first reported a position in Arcus Biosciences in Q2 2022 and has held it in 17 quarters since.
  • State of Alaska Department of Revenue's Arcus Biosciences position peaked at $1.03M in Q4 2025.
  • 117 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.